Ask AI
PARADIGM
PARADIGM: Randomized Phase II Trial of Azacitidine + Venetoclax vs Conventional Intensive Chemotherapy for Fit Patients With Newly Diagnosed AML

Released: December 12, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: December 12, 2025